Bupropion/zonisamide
Bupropion/Zonisamide[edit | edit source]
Bupropion/zonisamide is a combination of two pharmacological agents, bupropion and zonisamide, which are used in the treatment of various conditions, including depression, obesity, and epilepsy. This combination leverages the unique mechanisms of action of each drug to provide therapeutic benefits.
Bupropion[edit | edit source]
Bupropion is an atypical antidepressant that primarily acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It is commonly used to treat major depressive disorder and seasonal affective disorder. Bupropion is also prescribed as an aid to smoking cessation under the brand name Zyban.
Mechanism of Action[edit | edit source]
Bupropion works by inhibiting the reuptake of norepinephrine and dopamine, two neurotransmitters involved in mood regulation. This action increases the concentration of these neurotransmitters in the synaptic cleft, enhancing neurotransmission and improving mood.
Side Effects[edit | edit source]
Common side effects of bupropion include insomnia, dry mouth, and headache. It is important to note that bupropion lowers the seizure threshold, which can increase the risk of seizures in susceptible individuals.
Zonisamide[edit | edit source]
Zonisamide is an anticonvulsant medication used primarily in the treatment of epilepsy. It is also used off-label for weight loss and as an adjunct in the treatment of bipolar disorder.
Mechanism of Action[edit | edit source]
Zonisamide works by blocking sodium channels and reducing calcium influx, which stabilizes neuronal membranes and suppresses abnormal electrical activity in the brain. It also has a weak inhibitory effect on carbonic anhydrase, which may contribute to its anticonvulsant properties.
Side Effects[edit | edit source]
Common side effects of zonisamide include drowsiness, dizziness, and anorexia. It can also cause metabolic acidosis and kidney stones in some patients.
Combination Use[edit | edit source]
The combination of bupropion and zonisamide is used to exploit the complementary mechanisms of action of both drugs. Bupropion's effects on mood and energy levels can be enhanced by zonisamide's stabilizing effects on neuronal activity. This combination is sometimes used in the management of obesity due to the appetite-suppressing effects of both drugs.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
